Open Access. Powered by Scholars. Published by Universities.®
- Keyword
-
- FDA (2)
- SCOTUS (2)
- American food (1)
- Cigarette (1)
- Cipollone (1)
-
- Contamination (1)
- Courtney I. P. Thomas (1)
- Department of Agriculture (1)
- Drug (1)
- FDCA (1)
- Federal (1)
- Food (1)
- Food Drug and Cosmetic Act (1)
- Food and Drug Administration (1)
- Health risk (1)
- Labeling (1)
- Levine (1)
- Phenergan (1)
- Politics (1)
- Preemption (1)
- Prescription (1)
- Prescription drug labeling (1)
- Pure (1)
- Smoking (1)
- Statutory interpretation (1)
- Supreme Court (1)
- Tobacco (1)
- USDA (1)
- Warning (1)
- Wyeth (1)
Articles 1 - 5 of 5
Full-Text Articles in Law
Time For A Fresh Look At Strict Liability For Pharmaceuticals, Mary J. Davis
Time For A Fresh Look At Strict Liability For Pharmaceuticals, Mary J. Davis
Law Faculty Scholarly Articles
Part I provides a brief and basic explanation of pharmaceutical liability treatment. Part II explains the impact of federal preemption doctrine, which has dramatically limited the operation of tort law in pharmaceutical liability cases. Part III explains the parallel trends in the marketing and use of pharmaceuticals that increase the incidence of adverse drug events, affect prescribing practices, and fail to enhance informed practitioner and consumer choice in use of pharmaceuticals. Part IV provides support for the application of strict liability given the convergence of these trends. This Part also provides a theoretical justification for strict liability in tort for …
The Current State Of Opioid Litigation, Richard C. Ausness
The Current State Of Opioid Litigation, Richard C. Ausness
Law Faculty Scholarly Articles
Opioid litigation began around the turn of the century and mostly involved unsuccessful lawsuits by addicts against the manufacturers of prescription opioids. The landscape began to change several years ago when a number of state and local governments filed lawsuits against opioid drug manufacturers, seeking damages and other relief for the social and economic consequences of widespread opioid addiction in their territory. Since then, hundreds of government entities (hereinafter referred to as "government plaintiffs") have sued the manufacturers, distributors, prescribers, retail sellers, corporate officers and physician promoters of opioid products (hereinafter referred to as "defendants"). When I began working on …
Keeping Up With New Legal Titles, Franklin L. Runge
Keeping Up With New Legal Titles, Franklin L. Runge
Law Faculty Scholarly Articles
In this book review, Franklin L. Runge discusses In Food We Trust: The Politics of Purity in American Food Regulation by Courtney I. P. Thomas.
The Impact Of Wyeth V. Levine On Fda Regulation Of Prescription Drugs, Richard C. Ausness
The Impact Of Wyeth V. Levine On Fda Regulation Of Prescription Drugs, Richard C. Ausness
Law Faculty Scholarly Articles
On March 4, 2009, the United States Supreme Court decided Wyeth v. Levine. In that case, the Court concluded that the plaintiff's failure to warn claim against the makers of the drug Phenergan was not impliedly preempted by the Food, Drug and Cosmetic Act (FDCA). In doing so, the Court rejected the argument of the U.S. Food and Drug Administration (FDA) that tort claims of this nature stand as an obstacle to federal regulatory objectives. This article evaluates the Court's opinion in Wyeth and examines that decision's impact on subsequent litigation in the area of prescription drug labeling. In …
The Impact Of The Cipollone Case On Federal Preemption Law, Richard C. Ausness
The Impact Of The Cipollone Case On Federal Preemption Law, Richard C. Ausness
Law Faculty Scholarly Articles
The United States Supreme Court handed down an opinion in the Cipollone case on June 24, 1992. Justice Stevens, writing for the majority, concluded that the Federal Cigarette Labeling and Advertising Act preempted all tort claims against cigarette manufacturers based on failure to provide adequate warnings about the health risks of smoking. However, the Court also held that claims based on breach of express warranty, misrepresentation, and conspiracy were not preempted by the Act. Thus, although Cipollone represents a clear victory for tobacco companies, it also leaves the door open for future litigation. The first part of this Article will …